Kolexia
Zuily Stephane
Cardiologie
Hôpital Brabois
Vandoeuvre-lès-Nancy, France
380 Activités
1.8 K Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Syndrome des anticorps antiphospholipides Thrombose Lupus érythémateux disséminé COVID-19 Thromboembolisme veineux Thrombose veineuse Thrombopénie Embolie pulmonaire Anévrysme

Industries

BMS
21 collaboration(s)
Dernière en 2023
Pfizer
20 collaboration(s)
Dernière en 2023
Bayer
11 collaboration(s)
Dernière en 2022
GSK
9 collaboration(s)
Dernière en 2023

Dernières activités

BAT-VTE: Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets
Essai Clinique (CHU Saint-Étienne)   05 mars 2024
Response to Correspondence on "A Diagnostic Performance Study of the 2023 ACR/EULAR Classification Criteria For Antiphospholipid Syndrome (APS) in Cohorts of Patients Presenting with Suspected APS" by Lu et al.
Arthritis & rheumatology (Hoboken, N.J.)   25 février 2024
Thrombin Generation Assay in Antiphospholipid Antibodies Positive Subjects as a Personalized Thrombotic Risk Assessment: State of the Art and Perspectives.
Current rheumatology reports   19 février 2024
OBSTINATE: OBServaToire INternational Des Patients AnTiphospholipidEs traités Par Anticoagulants Oraux Directs
Essai Clinique (Stéphane Zuily)   07 février 2024
Membranous nephropathy in primary antiphospholipid syndrome.
Clinical kidney journal   02 février 2024
Response to "Correspondence/Comments on ACR/EULAR Antiphospholipid Syndrome Classification Criteria" by Alijotas-Reig et al.
Arthritis & rheumatology (Hoboken, N.J.)   11 janvier 2024
Thrombin-driven Neural Net Diagnoses the Antiphospholipid Syndrome without the Need for Interruption of Anticoagulation.
Blood advances   01 janvier 2024
Response to: Correspondence on '2023 ACR/EULAR antiphospholipid syndrome classification criteria' by Tang .
Annals of the rheumatic diseases   21 novembre 2023
Response to: Correspondence on 'ACR/EULAR antiphospholipid syndrome classification criteria' by Damoiseaux and van Beers.
Annals of the rheumatic diseases   21 novembre 2023
Response to: Correspondence on '2023 ACR/EULAR antiphospholipid syndrome classification criteria' by Miro-Mur .
Annals of the rheumatic diseases   21 novembre 2023